|
|
|
Insider
Information: |
Bobo Donald E Jr |
Relationship: |
CVP,Strategy/Corp Deve... |
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
46,936 |
|
Indirect Shares
|
173,767 |
|
|
Direct
Value |
$1,398,927 |
|
|
Indirect Value
|
$5,179,125 |
|
|
Total
Shares |
220,703 |
|
|
Total
Value |
$6,578,053 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
105.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
CVP,Strategy/Corp Deve... |
2024-05-11 |
46,936 |
2024-05-11 |
173,767 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
324 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 13
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-03-08 |
4 |
AS |
$76.96 |
$517,558 |
D/D |
(6,725) |
62,561 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-08-06 |
4 |
S |
$77.28 |
$927,378 |
I/I |
(12,000) |
111,696 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-01-09 |
4 |
AS |
$77.50 |
$521,188 |
D/D |
(6,725) |
62,561 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-11-06 |
4 |
S |
$78.01 |
$27,069 |
I/I |
(347) |
630 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-08-14 |
4 |
AS |
$78.75 |
$1,029,605 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-08-14 |
4 |
AS |
$79.30 |
$356,850 |
D/D |
(4,500) |
39,503 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-11-13 |
4 |
AS |
$80.52 |
$1,053,260 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-02-06 |
4 |
AS |
$80.75 |
$543,044 |
D/D |
(6,725) |
62,561 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2009-11-18 |
4 |
S |
$81.03 |
$202,575 |
D/D |
(2,500) |
16,613 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2014-04-14 |
4 |
AS |
$82.00 |
$2,050,000 |
D/D |
(25,000) |
20,604 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-09-11 |
4 |
AS |
$82.42 |
$1,077,988 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-10-09 |
4 |
AS |
$82.61 |
$1,079,997 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2021-03-12 |
4 |
AS |
$82.85 |
$1,083,375 |
D/D |
(13,077) |
48,508 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-04-06 |
4 |
AS |
$83.09 |
$558,801 |
D/D |
(6,725) |
62,824 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-11-09 |
4 |
S |
$83.89 |
$19,030 |
I/I |
(227) |
403 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2012-05-11 |
4 |
AS |
$84.24 |
$2,614,392 |
D/D |
(30,800) |
20,877 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-08-28 |
4 |
S |
$84.26 |
$606,694 |
I/I |
(7,200) |
123,820 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2021-04-09 |
4 |
AS |
$84.27 |
$1,102,046 |
D/D |
(13,077) |
48,845 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2012-05-07 |
4 |
AS |
$84.46 |
$2,041,791 |
D/D |
(24,000) |
22,278 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-12-11 |
4 |
AS |
$84.63 |
$1,106,699 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2012-05-07 |
4 |
D |
$84.99 |
$72,921 |
D/D |
(858) |
46,278 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-10-10 |
4 |
AS |
$85.00 |
$571,625 |
D/D |
(6,725) |
62,561 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2024-05-03 |
4 |
D |
$85.06 |
$40,744 |
D/D |
(479) |
39,289 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2024-05-07 |
4 |
D |
$85.09 |
$52,671 |
D/D |
(619) |
47,750 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2024-05-04 |
4 |
D |
$85.25 |
$296,244 |
D/D |
(3,475) |
41,669 |
0 |
- |
|
324 Records found
|
|
Page 8 of 13 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|